Patterson Companies, Inc. Stock Berne S.E.

Equities

PD2

US7033951036

Medical Equipment, Supplies & Distribution

Delayed Berne S.E. 5-day change 1st Jan Change
- CHF -.--% Intraday chart for Patterson Companies, Inc. -.--% -.--%

Financials

Sales 2025 * 6.73B 6.03B 9.2B Sales 2026 * 6.95B 6.23B 9.5B Capitalization 2.12B 1.9B 2.9B
Net income 2025 * 186M 167M 254M Net income 2026 * 199M 178M 272M EV / Sales 2025 * 0.38 x
Net Debt 2025 * 427M 383M 584M Net Debt 2026 * 364M 327M 498M EV / Sales 2026 * 0.36 x
P/E ratio 2025 *
11.7 x
P/E ratio 2026 *
10.9 x
Employees -
Yield 2025 *
4.41%
Yield 2026 *
4.46%
Free-Float 88.39%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 56 18-06-28
Director of Finance/CFO 46 17-12-31
Compliance Officer - 20-02-29
Members of the board TitleAgeSince
Chairman 74 06-11-30
Director/Board Member 68 11-08-31
Chief Executive Officer 56 18-06-28
More insiders
Patterson Companies, Inc. is a value-added specialty distributor serving the United States and Canadian dental supply markets and the United States, Canadian and United Kingdom animal health supply markets. The Company’s segments include Dental, Animal Health and Corporate. Its Dental segment provides consumable products (including infection control, restorative materials, and instruments); basic and advanced technology and dental equipment, and practice optimization solutions, including practice management software, e-commerce, revenue cycle management, patient engagement solutions, and clinical and patient education. Its Animal Health segment is a full-line distributor in North America and the United Kingdom of animal health products, services and technologies to both the production-animal and companion-pet markets. It offers a private label portfolio of products to veterinarians, producers, and retailers through its Aspen, First Companion and Patterson Veterinary brands.
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
13
Last Close Price
24.18 USD
Average target price
28.64 USD
Spread / Average Target
+18.43%
Consensus